Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
CC transcript
Director departure

SIGA TECHNOLOGIES INC (SIGA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023 - In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® -"
07/28/2023 8-K Quarterly results
07/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®"
05/04/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
03/02/2023 8-K Quarterly results
Docs: "- Corporate Update Conference Call Today at 4:30 PM ET -"
01/17/2023 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/24/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/03/2022 8-K Quarterly results
12/15/2021 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "- Up to Approximately $113 Million of Oral TPOXX® Targeted for Delivery to the U.S. Government in the Fourth Quarter - - Approximately $13 Million of International Sales for the First Nine Months of 2021 -"
09/15/2021 8-K Quarterly results
09/09/2021 8-K Quarterly results
08/05/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021 - Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter - - Authorization of Additional $50 Million Share Repurchase Program -"
06/17/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
03/04/2021 8-K Quarterly results
01/22/2021 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Third Amended and Restated Employment Agreement, between SIGA Technologies, Inc. and Robin E. Abrams"
01/13/2021 8-K Quarterly results
12/11/2020 8-K Appointed a new director
Docs: "Third Amended and Restated Employment Agreement, between SIGA Technologies, Inc. and Dennis E. Hruby"
11/05/2020 8-K Quarterly results
Docs: "- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government – - In October, the Public Health Agency of Canada Announced its Intent to Purchase up to 33,300 Courses of Oral TPOXX® –"
10/02/2020 8-K Quarterly results
08/06/2020 8-K Quarterly results
08/06/2020 8-K Quarterly results
06/26/2020 8-K Quarterly results
06/18/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy